[go: up one dir, main page]

PL3145490T3 - Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie - Google Patents

Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie

Info

Publication number
PL3145490T3
PL3145490T3 PL15728175T PL15728175T PL3145490T3 PL 3145490 T3 PL3145490 T3 PL 3145490T3 PL 15728175 T PL15728175 T PL 15728175T PL 15728175 T PL15728175 T PL 15728175T PL 3145490 T3 PL3145490 T3 PL 3145490T3
Authority
PL
Poland
Prior art keywords
dgla
gamma
preparations
linolenic acid
dihomo
Prior art date
Application number
PL15728175T
Other languages
English (en)
Inventor
Giovanni Brotzu
Giuseppe BROTZU
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of PL3145490T3 publication Critical patent/PL3145490T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PL15728175T 2014-05-06 2015-05-05 Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie PL3145490T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITCA20140003 2014-05-06
EP15728175.9A EP3145490B1 (en) 2014-05-06 2015-05-05 Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof
PCT/IB2015/053267 WO2015170247A1 (en) 2014-05-06 2015-05-05 Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof

Publications (1)

Publication Number Publication Date
PL3145490T3 true PL3145490T3 (pl) 2018-08-31

Family

ID=51136572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15728175T PL3145490T3 (pl) 2014-05-06 2015-05-05 Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie

Country Status (12)

Country Link
EP (1) EP3145490B1 (pl)
DK (1) DK3145490T3 (pl)
EA (1) EA029823B1 (pl)
ES (1) ES2673627T3 (pl)
HR (1) HRP20180866T1 (pl)
HU (1) HUE037543T2 (pl)
PL (1) PL3145490T3 (pl)
SA (1) SA516380231B1 (pl)
SI (1) SI3145490T1 (pl)
SM (1) SMT201800275T1 (pl)
TR (1) TR201808036T4 (pl)
WO (1) WO2015170247A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800005309A1 (it) * 2018-05-11 2019-11-11 Composizione ad attivita’ antimicrobica
IT202300018066A1 (it) * 2023-09-04 2025-03-04 Giuseppe Brotzu Liposomi gastroresistenti contenenti magnesio solfato e acido dihomo-gamma-linoleico, l-propionil-carnitina, o-beta-hydroxyethil-rutoside e altre molecole, formulazioni varie.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120809A (ja) * 1983-11-30 1985-06-28 Akira Kitano 脱毛防止及び、養毛、発毛用シヤンプ−
EP0309086A1 (en) * 1987-09-07 1989-03-29 Efamol Holdings Plc Treatment of male pattern baldness and of unwanted hair growth
FR2711060B1 (fr) * 1993-10-13 1995-11-17 Oreal Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US8067470B2 (en) * 2008-02-01 2011-11-29 Mcdaniel William Robert Linoleic acid preparations for the topical treatment of male and female pattern androgenetic alopecia, age-related alopecia, and keratosis pilaris
IT1397867B1 (it) * 2010-02-03 2013-02-04 Brotzu Liposomi contenenti prostaglandina e1 (pge1), formulazioni che li contengono e loro uso
ITFI20120092A1 (it) * 2012-05-14 2013-11-15 Giovanni Brotzu Liposomi contenenti prostaglandina e1 (pge1) ed un estrogeno vegetale, formulazioni per uso topico che li contengono e loro uso.

Also Published As

Publication number Publication date
WO2015170247A1 (en) 2015-11-12
EA201650066A1 (ru) 2017-04-28
EP3145490B1 (en) 2018-03-28
DK3145490T3 (en) 2018-06-25
EP3145490A1 (en) 2017-03-29
SI3145490T1 (sl) 2018-09-28
HRP20180866T1 (hr) 2018-08-24
HUE037543T2 (hu) 2018-09-28
TR201808036T4 (tr) 2018-06-21
SMT201800275T1 (it) 2018-07-17
SA516380231B1 (ar) 2020-11-03
EA029823B1 (ru) 2018-05-31
ES2673627T3 (es) 2018-06-25

Similar Documents

Publication Publication Date Title
IL264454A (en) Novel compositions, uses and methods for making them
IL256260B (en) Treprostinil derivatives and compositions and uses thereof
IL256652A (en) Therapeutic compositions, combinations, and methods of use
HUE049341T2 (hu) Szubsztituált indazolok, eljárás ezek elõállítására, ezeket tartalmazó gyógyszerkészítmények, valamint ezek alkalmazása gyógyszerkészítmények elõállítására
HRP20180501T1 (hr) Pripravci koje sadrže bakterijske sojeve
IL249061B (en) Combination, composition, and method of administering the combination or composition to animals
IL247262A0 (en) Cannabinoid compositions and uses
IL249197A0 (en) Stable cannabinoid formulations
EP3337502A4 (en) STABLE ANTI-IFNAR1 FORMULATION
DK3142637T3 (da) Keratin treatment formulations and methods
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
DK3587417T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
HUE053101T2 (hu) Javított T-sejt-készítmények
IL240195A0 (en) Pyridone amide compounds, compositions comprising same and uses thereof
IL247458A0 (en) Methods and compositions for increasing a t-effector cell to regulatory t cell ratio
HRP20241144T8 (hr) Stabilne formulacije lipida i lipozoma
IL246987B (en) Herteroaryl amides, compositions comprising same and uses thereof
BR112017001684A2 (pt) preparação de produto de proteína de pulso ("yp810")
DK3310340T3 (da) Formulering med høj koncentration
DK3608334T3 (da) Tatk-cdkl5-fusionsproteiner, sammensætninger, formuleringer og anvendelse deraf
DK3265057T3 (da) Topisk formulering
IL251345A0 (en) Compositions for use in the treatment of peri-implantitis
IL234929B (en) Liposomes-containing antifouling compositions and uses thereof
IL249560A0 (en) Pyridinones converted with phenyl and tertbutyl acetic acid have anti-AIDS effects
HUE054749T2 (hu) Kevert készítmények